Lactobacillus rhamnosus postbiotic-induced immunomodulation as safer alternative to the use of live bacteria

Cytokine. 2021 Oct:146:155631. doi: 10.1016/j.cyto.2021.155631. Epub 2021 Jul 10.

Abstract

Many attempts have been made to search for safer immunomodulatory agents that enhance the immune response and reduce the number and severity of infections in at-risk populations. The use of postbiotics, non-viable microbial cells or cell fractions that confer a health benefit to the consumer, represents a safe and attractive way to modulate and enhance the immune function in order to improve human health. Therefore, the aim of this work is to evaluate the immunoregulatory effect of Lactobacillus rhamnosus CRL1505 postbiotics in a complex culture system using human intestinal epithelial cells (IECs) and dendritic cells (DCs) differentiated from peripheral blood mononuclear cells. First, we demonstrated that L. rhamnosus CRL1505 differentially modulate human IECs and DCs after the challenge with the TLR4 agonist LPS. The CRL1505 strain down-regulated CD40, CD80 and CD86 expression in DCs, and increased their production of TNF-α, IL-1β, IL-6 and IL-10. Interestingly, the non-viable strain was able to modulate the immune response of both types of human cells. Then, we showed that cell wall (CW1505) and peptidoglycan (PG1505) from L. rhamnosus CRL1505 modulated TLR4-triggered immune response in IECs and DCs. Of interest, CW1505 showed a strong stimulatory effect while the PG1505 presented immune characteristics that were more similar to viable and non-viable CRL1505. To date, several molecules of immunobiotics were identified, that can be connected to specific host-responses. We hereby demonstrated that peptidoglycan of L. rhamnosus CRL1505 is a key molecule for the immunobiotic properties of this strain in human IECs and DCs. Likewise, the result of these studies could provide predictive tools for the in vivo efficacy of postbiotics and the scientific basis for their future applications in immunocompromised patients.

Keywords: Cellular fractions; Human dendritic cells; Human intestinal epithelial cells; Immunomodulatory properties; Lactobacillus rhamnosus CRL1505; Peptidoglycan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines / metabolism
  • Dendritic Cells / metabolism
  • Enterocytes / metabolism
  • HT29 Cells
  • Humans
  • Immunomodulation*
  • Lacticaseibacillus rhamnosus / immunology*
  • Microbial Viability
  • Models, Biological
  • NF-kappa B / metabolism

Substances

  • Cytokines
  • NF-kappa B